US equities |
MU $878.84 ▼-5.63% NVDA $214.13 ▼-1.43% TSLA $354.72 ▼-2.13% AAPL $343.46 ▲+0.43% META $709.33 ▼-3.72% MSFT $529.05 ▼-1.93% SPCX $146.03 ▼-1.74% AMD $528.75 ▼-5.95%
FinancialContent

Articles published by Rocket Pharmaceuticals

News headline image
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial and Operational Results
From Rocket Pharmaceuticals
Via Business Wire
Tickers RCKT
News headline image
Rocket Pharmaceuticals Highlights Anticipated 2022 Milestones Across Lentiviral and AAV Gene Therapy Clinical Programs
From Rocket Pharmaceuticals
Via Business Wire
Tickers RCKT